Cargando…
Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for causing coronavirus disease 2019 (COVID-19), marked the third time in the twenty-first century when a new, highly pathogenic human coronavirus outbreak has led to an epidemic. The COVID-19 epidemic has...
Autores principales: | Kumari, Puja, Rawat, Kajal, Saha, Lekha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367788/ https://www.ncbi.nlm.nih.gov/pubmed/32837854 http://dx.doi.org/10.1007/s40495-020-00226-5 |
Ejemplares similares
-
The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic
por: Dan, Siddhartha, et al.
Publicado: (2020) -
Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
por: Satarker, Sairaj, et al.
Publicado: (2020) -
Colchicine in COVID-19: an Old Drug, New Use
por: Schlesinger, Naomi, et al.
Publicado: (2020) -
Nutritional Aspects of People Living with HIV (PLHIV) Amidst COVID-19 Pandemic: an Insight
por: S, Fathima A., et al.
Publicado: (2022) -
Histone H3 Mutations in Cancer
por: Wan, Yi Ching Esther, et al.
Publicado: (2018)